Vietnam Over The Counter (OTC) Drugs Market, By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage

Vietnam Over The Counter (OTC) Drugs Market, By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027

Vietnam over the counter (OTC) drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of expanding pharmaceutical industry of the country. Vietnam's healthcare industry does not have the capable resources for consistent research and advancement in drug designing, pharmacy advancement, etc. Therefore, the local pharmaceutical manufacturers and contract manufacturing organizations are solely invested in the manufacturing of generics, biosimilars, and over-the-counter (OTC) drugs, thus driving the growth of Vietnam over the counter (OTC) drugs market in the upcoming five years.

Over-the-counter, (OTC) drugs are non-prescription-based medicines that are usually sold without any legal prescription and are often with no side effects. These drugs are safe and do not have any addictive nature if consumed un-monitored or without a physician's prescription. Although, as a general awareness physicians often advise to consult doctors and experts regarding illness before self-prescribing any kind of medicine. Basic cold medicines, vitamin tablets, or health supplements are different categories of over-the-counter (OTC) drugs.

Expanding Pharmaceutical Industry Satisfies Demand

Demand for counter (OTC) drugs is expediting due to rapid demands from the common population of the country. Although, due to the increasing population that can spend more on branded drugs and new advanced medicine, still a large portion of the total population, exceeding 98 million population is inclined toward generic drugs, OTC drugs, and biosimilars. The growing pharmaceutical industry is also stabilized due to the consistent flow of investments in the form of government financial assistance.

In the year, 2018 Vietnam's pharmaceutical industry was valued at USD5.34 billion. The industrial production index in the year exceeded 121.8 in the year 2020, demonstrating higher production and manufacturing of pharmaceutical products like OTC drugs, thus substantiating the growth of the Vietnam OTC drugs market in the future five years.

Market Segmentation

The Vietnam over-the-counter (OTC) drugs market is segmented by product, route of administration, dosage forms, distribution channel, competitional landscape, and regional distribution. Based on product, the market is further segmented into a cough, cold, and flu; vitamins, minerals, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. The market is also fragmented based on the route of administration of the drugs into oral, topical, and parenteral. Based on dosage form, the market is bifurcated into tablets, capsules, liquids & solutions, creams/ lotions/ ointments, and others. By distribution channel, the market is differentiated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Northern region, Central region, and the Southern region.

Company Profile

Sanofi-Aventis Vietnam Company, GlaxoSmithKline Vietnam, Reckitt Benckiser Vietnam, Imexpharm Pharmaceutical Joint Stock Company, DHG Pharmaceutical Joint Stock Company, Traphaco Joint Stock Company, Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, Vimedimex Medi-Pharma Joint Stock Company, Vietnam Pharmaceutical Corporation, Ha Tay Pharmaceutical Joint Stock Company, among others is a partial list of major market players of the companies responsible for the growth of Vietnam over the counter (OTC) drugs market.

Report Scope:

In this report, Vietnam over the counter (OTC) drugs market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vietnam Over The Counter (OTC) Drugs Market, By Product:
• Cough, Cold, and Flu
• Vitamins, Mineral, and Supplements (VMS)
• Analgesics
• Gastrointestinal Products
• Dermatology Products
• Others
• Vietnam Over The Counter (OTC) Drugs Market, By Route of Administration:
• Oral
• Topical
• Parenteral
• Vietnam Over the counter (OTC) drugs Market, By Dosage Form:
• Tablets
• Capsules
• Liquids & Solution
• Creams/Lotions/Ointments
• Others
• Vietnam Over The Counter (OTC) Drugs Market, By Distribution Channel:
• Retail Pharmacy
• Hospital Pharmacy
• E-Pharmacy
• Vietnam Over The Counter (OTC) Drugs Market, By Region:
• Northern Region
• Central Region
• Southern Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Vietnam over the counter (OTC) drugs market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights